383 related articles for article (PubMed ID: 18182779)
1. Red blood cells are the major source of alpha-synuclein in blood.
Barbour R; Kling K; Anderson JP; Banducci K; Cole T; Diep L; Fox M; Goldstein JM; Soriano F; Seubert P; Chilcote TJ
Neurodegener Dis; 2008; 5(2):55-9. PubMed ID: 18182779
[TBL] [Abstract][Full Text] [Related]
2. Determination of alpha-synuclein concentration in human plasma using ELISA.
Fjorback AW; Varming K; Jensen PH
Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
[TBL] [Abstract][Full Text] [Related]
3. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
Shults CW; Barrett JM; Fontaine D
Neurosci Lett; 2006 Sep; 405(3):223-5. PubMed ID: 16901642
[TBL] [Abstract][Full Text] [Related]
4. Sensitive and specific detection of α-synuclein in human plasma.
Tinsley RB; Kotschet K; Modesto D; Ng H; Wang Y; Nagley P; Shaw G; Horne MK
J Neurosci Res; 2010 Sep; 88(12):2693-700. PubMed ID: 20648655
[TBL] [Abstract][Full Text] [Related]
5. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
Li QX; Mok SS; Laughton KM; McLean CA; Cappai R; Masters CL; Culvenor JG; Horne MK
Exp Neurol; 2007 Apr; 204(2):583-8. PubMed ID: 17258710
[TBL] [Abstract][Full Text] [Related]
6. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
Häbig K; Walter M; Stappert H; Riess O; Bonin M
Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
[TBL] [Abstract][Full Text] [Related]
7. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease.
Michell AW; Luheshi LM; Barker RA
Neurosci Lett; 2005 Jun; 381(3):294-8. PubMed ID: 15896487
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities.
Lee HJ; Bae EJ; Jang A; Ho DH; Cho ED; Suk JE; Yun YM; Lee SJ
J Neurosci Methods; 2011 Aug; 199(2):249-57. PubMed ID: 21658411
[TBL] [Abstract][Full Text] [Related]
9. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage.
Nakai M; Fujita M; Waragai M; Sugama S; Wei J; Akatsu H; Ohtaka-Maruyama C; Okado H; Hashimoto M
Biochem Biophys Res Commun; 2007 Jun; 358(1):104-10. PubMed ID: 17475220
[TBL] [Abstract][Full Text] [Related]
10. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
11. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
12. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
Kramer ML; Behrens C; Schulz-Schaeffer WJ
Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol.
Walker SJ; Grant KA
Alcohol; 2006 Jan; 38(1):1-4. PubMed ID: 16762686
[TBL] [Abstract][Full Text] [Related]
15. alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice.
Ziolkowska B; Gieryk A; Wawrzczak-Bargiela A; Krowka T; Kaminska D; Korkosz A; Bienkowski P; Przewlocki R
Neuropharmacology; 2008 Jun; 54(8):1239-46. PubMed ID: 18456291
[TBL] [Abstract][Full Text] [Related]
16. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ; Choi MY; Im H
Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
[TBL] [Abstract][Full Text] [Related]
17. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.
Lee HJ; Suk JE; Bae EJ; Lee JH; Paik SR; Lee SJ
Int J Biochem Cell Biol; 2008; 40(9):1835-49. PubMed ID: 18291704
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
19. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells.
Bick RJ; Poindexter BJ; Kott MM; Liang YA; Dinh K; Kaur B; Bick DL; Doursout MF; Schiess MC
Brain Res; 2008 Jun; 1217():203-12. PubMed ID: 18501880
[TBL] [Abstract][Full Text] [Related]
20. A more efficient enzyme-linked immunosorbent assay for measurement of alpha-synuclein in cerebrospinal fluid.
van Geel WJ; Abdo WF; Melis R; Williams S; Bloem BR; Verbeek MM
J Neurosci Methods; 2008 Feb; 168(1):182-5. PubMed ID: 17976734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
